B
Exchange
—
Entity type
operating
Fiscal year end
Sep 30
Headquarters
DE
Recent Filings
- 10-Q5.9 MBBIOVEST INTERNATIONAL INCFeb 14, 11:53 AM ET·0001214659-14-001182
- 10-K14.8 MBBIOVEST INTERNATIONAL INCDec 27, 4:48 PM ET·0001214659-13-007303
- 45.4 KBBIOVEST INTERNATIONAL INCDec 27, 2:51 PM ET·0001214659-13-007300
- 45.3 KBBIOVEST INTERNATIONAL INCDec 27, 2:50 PM ET·0001214659-13-007299
- 45.3 KBBIOVEST INTERNATIONAL INCDec 27, 2:49 PM ET·0001214659-13-007298
- 35.1 KBBIOVEST INTERNATIONAL INCDec 10, 5:05 PM ET·0001214659-13-006966
- 8-K191.5 KBBIOVEST INTERNATIONAL INCDec 5, 4:01 PM ET·0001214659-13-006907
- 418.3 KBBIOVEST INTERNATIONAL INCAug 23, 3:46 PM ET·0001214659-13-004884
- 416.8 KBBIOVEST INTERNATIONAL INCAug 23, 3:45 PM ET·0001214659-13-004883
- 419.0 KBBIOVEST INTERNATIONAL INCAug 23, 3:45 PM ET·0001214659-13-004882
Insiders
10- ACCENTIA BIOPHARMACEUTICALS INC10% Owner
- ARIKIAN STEVEN10% Owner
- BAUM MARTINDirector, 10% Owner
- BELLEAU THOMAS FChief Financial Officer
- Bottjer Brian DActing Chief Financial Officer
- Calder Douglas WVP Strategic Plan/Cap Markets
- CHAPMAN CHRISTOPHER CDirector
- DUFFEY SAMUEL SPRESIDENT & GENERAL COUNSEL
- FARRELL ROBERT EDWARDCHIEF FINANCIAL OFFICER
- GRIN DAVID10% Owner, Disclaimed Group
Tickers
No tickers on record
Addresses
business
324 S HYDE PARK AVE SUITE 350
TAMPA, FL, 33606
mailing
324 S HYDE PARK AVE SUITE 350
TAMPA, FL, 33606
Former Names
- CELLEX BIOSCIENCES INC2001-05-16